Pular para o conteúdo
Merck
  • mRNA Structural constraints on EBNA1 synthesis impact on in vivo antigen presentation and early priming of CD8+ T cells.

mRNA Structural constraints on EBNA1 synthesis impact on in vivo antigen presentation and early priming of CD8+ T cells.

PLoS pathogens (2014-10-10)
Judy T Tellam, Jie Zhong, Lea Lekieffre, Purnima Bhat, Michelle Martinez, Nathan P Croft, Warren Kaplan, Ross L Tellam, Rajiv Khanna
RESUMO

Recent studies have shown that virally encoded mRNA sequences of genome maintenance proteins from herpesviruses contain clusters of unusual structural elements, G-quadruplexes, which modulate viral protein synthesis. Destabilization of these G-quadruplexes can override the inhibitory effect on self-synthesis of these proteins. Here we show that the purine-rich repetitive mRNA sequence of Epstein-Barr virus encoded nuclear antigen 1 (EBNA1) comprising G-quadruplex structures, limits both the presentation of MHC class I-restricted CD8(+) T cell epitopes by CD11c(+) dendritic cells in draining lymph nodes and early priming of antigen-specific CD8(+) T-cells. Destabilization of the G-quadruplex structures through codon-modification significantly enhanced in vivo antigen presentation and activation of virus-specific T cells. Ex vivo imaging of draining lymph nodes by confocal microscopy revealed enhanced antigen-specific T-cell trafficking and APC-CD8(+) T-cell interactions in mice primed with viral vectors encoding a codon-modified EBNA1 protein. More importantly, these antigen-specific T cells displayed enhanced expression of the T-box transcription factor and superior polyfunctionality consistent with the qualitative impact of translation efficiency. These results provide an important insight into how viruses exploit mRNA structure to down regulate synthesis of their viral maintenance proteins and delay priming of antigen-specific T cells, thereby establishing a successful latent infection in vivo. Furthermore, targeting EBNA1 mRNA rather than protein by small molecules or antisense oligonucleotides will enhance EBNA1 synthesis and the early priming of effector T cells, to establish a more rapid immune response and prevent persistent infection.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
2-Mercaptoetanol, for molecular biology, suitable for electrophoresis, suitable for cell culture, BioReagent, 99% (GC/titration)
Sigma-Aldrich
2-Mercaptoetanol, ≥99.0%
Sigma-Aldrich
L-Glutamina, meets USP testing specifications, suitable for cell culture, 99.0-101.0%, from non-animal source
Sigma-Aldrich
Piruvato de sódio, powder, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥99%
Sigma-Aldrich
L-Glutamina
Sigma-Aldrich
2-Mercaptoetanol, BioUltra, for molecular biology, ≥99.0% (GC)
Sigma-Aldrich
Brefeldina A, from Penicillium brefeldianum, ≥99% (HPLC and TLC)
Sigma-Aldrich
Piruvato de sódio, ReagentPlus®, ≥99%
SAFC
L-Glutamina
Sigma-Aldrich
Fluorescein, for fluorescence, free acid
Sigma-Aldrich
Brefeldina A, ≥99% (HPLC and TLC), BioXtra, for molecular biology
Sigma-Aldrich
Piruvato de sódio, Hybri-Max, powder, suitable for hybridoma
Sigma-Aldrich
Piruvato de sódio, powder, BioXtra, suitable for mouse embryo cell culture
Sigma-Aldrich
L-Glutamina, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
Brefeldina A, from Penicillium brefeldianum, Ready Made Solution, 10 mg/mL in DMSO
Sigma-Aldrich
L-Glutamina, γ-irradiated, BioXtra, suitable for cell culture
Supelco
2-Mercaptoetanol, for HPLC derivatization, LiChropur, ≥99.0% (GC)
Sigma-Aldrich
Piruvato de sódio, BioXtra, ≥99%
Sigma-Aldrich
L-Glutamina
Supelco
L-Glutamina, Pharmaceutical Secondary Standard; Certified Reference Material